| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
|
Eur Heart J
|
2013
|
9.54
|
|
2
|
PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.
|
Cell Metab
|
2007
|
7.19
|
|
3
|
T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.
|
Arterioscler Thromb Vasc Biol
|
2008
|
5.44
|
|
4
|
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
|
Eur Heart J
|
2013
|
5.23
|
|
5
|
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
|
Am J Cardiol
|
2008
|
1.88
|
|
6
|
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study.
|
J Am Coll Cardiol
|
2005
|
1.60
|
|
7
|
Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
|
Catheter Cardiovasc Interv
|
2013
|
1.49
|
|
8
|
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
|
Diabetes Care
|
2014
|
1.47
|
|
9
|
Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
|
JACC Cardiovasc Imaging
|
2011
|
1.47
|
|
10
|
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
|
J Am Coll Cardiol
|
2007
|
1.38
|
|
11
|
Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial.
|
Diab Vasc Dis Res
|
2013
|
1.36
|
|
12
|
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
|
Circulation
|
2014
|
1.32
|
|
13
|
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
|
Diab Vasc Dis Res
|
2008
|
1.27
|
|
14
|
Electromagnetic interference with implantable cardioverter-defibrillators at power frequency: an in vivo study.
|
Circulation
|
2013
|
1.26
|
|
15
|
Cryorecanalization: a new approach for the immediate management of acute airway obstruction.
|
J Thorac Cardiovasc Surg
|
2004
|
1.24
|
|
16
|
Optimized guidance of percutaneous edge-to edge repair of the mitral valve using real-time 3-D transesophageal echocardiography.
|
Clin Res Cardiol
|
2011
|
1.19
|
|
17
|
Repair after myocardial infarction, between fantasy and reality: the role of chemokines.
|
J Am Coll Cardiol
|
2011
|
1.18
|
|
18
|
C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase.
|
Diabetes
|
2004
|
1.17
|
|
19
|
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
|
Diab Vasc Dis Res
|
2014
|
1.10
|
|
20
|
C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
|
Circ Res
|
2006
|
1.08
|
|
21
|
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.07
|
|
22
|
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
|
Metabolism
|
2007
|
1.07
|
|
23
|
Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location.
|
Eur Heart J
|
2012
|
1.06
|
|
24
|
Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
|
Thromb Haemost
|
2011
|
1.06
|
|
25
|
Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction.
|
J Cardiovasc Magn Reson
|
2006
|
1.05
|
|
26
|
Comparison of two-dimensional and three-dimensional imaging techniques for measurement of aortic annulus diameters before transcatheter aortic valve implantation.
|
Heart
|
2011
|
1.05
|
|
27
|
LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.04
|
|
28
|
Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation.
|
Int J Cardiol
|
2010
|
1.03
|
|
29
|
PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice.
|
Cardiovasc Diabetol
|
2010
|
1.02
|
|
30
|
Acetylcholine as an age-dependent non-neuronal source in the heart.
|
Auton Neurosci
|
2010
|
0.98
|
|
31
|
Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells.
|
Mol Pharmacol
|
2002
|
0.97
|
|
32
|
Stabilization of atherosclerotic plaques: an update.
|
Eur Heart J
|
2013
|
0.96
|
|
33
|
The role of vitamin D in cardiovascular disease: from present evidence to future perspectives.
|
Atherosclerosis
|
2012
|
0.96
|
|
34
|
Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques.
|
Am J Pathol
|
2009
|
0.93
|
|
35
|
Characterization of patients with acute chest pain using cardiac magnetic resonance imaging.
|
Clin Res Cardiol
|
2008
|
0.92
|
|
36
|
The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization.
|
Clin Res Cardiol
|
2011
|
0.92
|
|
37
|
Evaluation of aortic root for definition of prosthesis size by magnetic resonance imaging and cardiac computed tomography: implications for transcatheter aortic valve implantation.
|
Int J Cardiol
|
2011
|
0.91
|
|
38
|
Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice.
|
Atherosclerosis
|
2008
|
0.89
|
|
39
|
Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.89
|
|
40
|
Quantitative analysis of endocardial and epicardial left ventricular myocardial deformation-comparison of strain-encoded cardiac magnetic resonance imaging with two-dimensional speckle-tracking echocardiography.
|
J Am Soc Echocardiogr
|
2012
|
0.89
|
|
41
|
Induction of CXCR2 receptor by peroxisome proliferator-activated receptor gamma in human macrophages.
|
Arterioscler Thromb Vasc Biol
|
2008
|
0.89
|
|
42
|
Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.
|
Am J Pathol
|
2002
|
0.88
|
|
43
|
Cardiovascular effects of incretin-based therapies.
|
Rev Diabet Stud
|
2011
|
0.88
|
|
44
|
Dual stack black blood carotid artery CMR at 3T: application to wall thickness visualization.
|
J Cardiovasc Magn Reson
|
2009
|
0.88
|
|
45
|
Medical options to fight mortality in end-stage renal disease: a review of the literature.
|
Nephrol Dial Transplant
|
2012
|
0.88
|
|
46
|
Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans.
|
Cardiovasc Diabetol
|
2013
|
0.87
|
|
47
|
Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study.
|
J Heart Valve Dis
|
2013
|
0.87
|
|
48
|
Impact of transcutaneous aortic valve implantation on myocardial deformation.
|
Echocardiography
|
2011
|
0.85
|
|
49
|
Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions.
|
Clin Res Cardiol
|
2013
|
0.85
|
|
50
|
Chronic electrical neuronal stimulation increases cardiac parasympathetic tone by eliciting neurotrophic effects.
|
Circ Res
|
2011
|
0.84
|
|
51
|
Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients.
|
Nephrol Dial Transplant
|
2012
|
0.84
|
|
52
|
Comparison of accuracy of mitral valve regurgitation volume determined by three-dimensional transesophageal echocardiography versus cardiac magnetic resonance imaging.
|
Am J Cardiol
|
2012
|
0.84
|
|
53
|
Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat model.
|
J Cell Mol Med
|
2012
|
0.84
|
|
54
|
Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma.
|
Hypertension
|
2007
|
0.83
|
|
55
|
Comparison of direct planimetry of mitral valve regurgitation orifice area by three-dimensional transesophageal echocardiography to effective regurgitant orifice area obtained by proximal flow convergence method and vena contracta area determined by color Doppler echocardiography.
|
Am J Cardiol
|
2011
|
0.83
|
|
56
|
Potential cardiovascular effects of incretin-based therapies.
|
Expert Rev Cardiovasc Ther
|
2012
|
0.83
|
|
57
|
Serum starvation and growth factor receptor expression in vascular smooth muscle cells.
|
J Vasc Res
|
2006
|
0.83
|
|
58
|
Optical coherence tomography derived differences of plaque characteristics in coronary culprit lesions between type 2 diabetic patients with and without acute coronary syndrome.
|
Catheter Cardiovasc Interv
|
2013
|
0.83
|
|
59
|
A score to quantify coronary plaque vulnerability in high-risk patients with type 2 diabetes: an optical coherence tomography study.
|
Cardiovasc Diabetol
|
2014
|
0.83
|
|
60
|
Layer-specific analysis of myocardial deformation for assessment of infarct transmurality: comparison of strain-encoded cardiovascular magnetic resonance with 2D speckle tracking echocardiography.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.82
|
|
61
|
Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging.
|
Int J Cardiovasc Imaging
|
2011
|
0.82
|
|
62
|
Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.
|
Heart Vessels
|
2013
|
0.82
|
|
63
|
Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion.
|
Cell Mol Neurobiol
|
2010
|
0.82
|
|
64
|
Electrical stimulation of sympathetic neurons induces autocrine/paracrine effects of NGF mediated by TrkA.
|
J Mol Cell Cardiol
|
2010
|
0.82
|
|
65
|
Comparative evaluation of the usability of 2 different methods to perform mild hypothermia in patients with out-of-hospital cardiac arrest.
|
Int J Cardiol
|
2010
|
0.82
|
|
66
|
Insulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic action.
|
Diab Vasc Dis Res
|
2004
|
0.81
|
|
67
|
Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?
|
Eur J Heart Fail
|
2012
|
0.81
|
|
68
|
Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study.
|
Diab Vasc Dis Res
|
2010
|
0.81
|
|
69
|
Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison.
|
Coron Artery Dis
|
2011
|
0.81
|
|
70
|
Real-time 3D TEE allows optimized guidance of percutaneous edge-to-edge repair of the mitral valve.
|
JACC Cardiovasc Imaging
|
2010
|
0.81
|
|
71
|
C-peptide promotes lesion development in a mouse model of arteriosclerosis.
|
J Cell Mol Med
|
2012
|
0.81
|
|
72
|
Inter-subject differences in constitutive expression levels of the clock gene in man.
|
Diab Vasc Dis Res
|
2007
|
0.81
|
|
73
|
Introduction of a high-throughput double-stent animal model for the evaluation of biodegradable vascular stents.
|
J Biomed Mater Res B Appl Biomater
|
2012
|
0.81
|
|
74
|
C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.
|
Curr Atheroscler Rep
|
2013
|
0.81
|
|
75
|
Relationship between optical coherence tomography derived intraluminal and intramural criteria and haemodynamic relevance as determined by fractional flow reserve in intermediate coronary stenoses of patients with type 2 diabetes.
|
Heart
|
2013
|
0.81
|
|
76
|
Effect of SDF-1 α on endogenous mobilized and transplanted stem cells in regeneration after myocardial infarction.
|
Curr Pharm Des
|
2014
|
0.81
|
|
77
|
Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease.
|
Clin Res Cardiol
|
2008
|
0.80
|
|
78
|
Functional and topographic concordance of right atrial neural structures inducing sinus tachycardia.
|
Adv Exp Med Biol
|
2013
|
0.80
|
|
79
|
Predictors and incidence of stent edge dissections in patients with type 2 diabetes as determined by optical coherence tomography.
|
Int J Cardiovasc Imaging
|
2013
|
0.80
|
|
80
|
Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation.
|
Atherosclerosis
|
2010
|
0.80
|
|
81
|
Drinking modulates monocyte migration in healthy subjects: a randomised intervention study of water, ethanol, red wine and beer with or without alcohol.
|
Diab Vasc Dis Res
|
2008
|
0.80
|
|
82
|
Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation.
|
Int J Cardiol
|
2011
|
0.80
|
|
83
|
Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function.
|
JACC Cardiovasc Interv
|
2012
|
0.80
|
|
84
|
Inflammatory parameters and prediction of prognosis in infective endocarditis.
|
BMC Infect Dis
|
2013
|
0.80
|
|
85
|
Mechanical stretch of sympathetic neurons induces VEGF expression via a NGF and CNTF signaling pathway.
|
Biochem Biophys Res Commun
|
2011
|
0.80
|
|
86
|
Analysis of procedural effects of percutaneous edge-to-edge mitral valve repair by 2D and 3D echocardiography.
|
Circ Cardiovasc Imaging
|
2012
|
0.80
|
|
87
|
Endothelial dysfunction and cardiovascular disease--the lull before the storm.
|
Diab Vasc Dis Res
|
2007
|
0.79
|
|
88
|
Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.
|
Semin Immunopathol
|
2009
|
0.79
|
|
89
|
Clinical Trials Update AHA Congress 2010.
|
Cardiovasc Drugs Ther
|
2011
|
0.79
|
|
90
|
Detection of coronary artery disease in postmenopausal women: the significance of integrated stress imaging tests in a 4-year prognostic study.
|
Clin Res Cardiol
|
2014
|
0.79
|
|
91
|
Impact of aortic valve calcification severity and impaired left ventricular function on 3-year results of patients undergoing transcatheter aortic valve replacement.
|
Eur Radiol
|
2013
|
0.78
|
|
92
|
The right ventricular response to high afterload: comparison between healthy persons and patients with transposition of the great arteries: a 2D strain study.
|
Echocardiography
|
2010
|
0.78
|
|
93
|
Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice.
|
Atherosclerosis
|
2013
|
0.78
|
|
94
|
Role of the adipocyte-specific NF-κB activity in the regulation of IP-10 and T cell migration.
|
Am J Physiol Endocrinol Metab
|
2010
|
0.78
|
|
95
|
Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest.
|
Int J Cardiol
|
2012
|
0.78
|
|
96
|
Age-related regional differences in cardiac nerve growth factor expression.
|
Age (Dordr)
|
2011
|
0.78
|
|
97
|
LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration.
|
Basic Res Cardiol
|
2010
|
0.78
|
|
98
|
Layer-specific strain-encoded MRI for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease.
|
Int J Cardiol
|
2011
|
0.78
|
|
99
|
Plaque vulnerability of coronary artery lesions is related to left ventricular dilatation as determined by optical coherence tomography and cardiac magnetic resonance imaging in patients with type 2 diabetes.
|
Cardiovasc Diabetol
|
2013
|
0.78
|
|
100
|
Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation.
|
J Heart Valve Dis
|
2011
|
0.78
|
|
101
|
Anticoagulant and antiplatelet therapy in patients with atrial fibrillation and coronary artery disease.
|
Thrombosis
|
2012
|
0.78
|
|
102
|
The Modified Glasgow Outcome Score for the prediction of outcome in patients after cardiac arrest: a prospective clinical proof of concept study.
|
Clin Res Cardiol
|
2012
|
0.77
|
|
103
|
Resistin: a newly identified chemokine for human CD4-positive lymphocytes.
|
Cardiovasc Res
|
2010
|
0.77
|
|
104
|
Glucagon-like peptide-1(9-36) inhibits chemokine-induced migration of human CD4-positive lymphocytes.
|
PLoS One
|
2013
|
0.77
|
|
105
|
Long-term clinical and angiographic outcome after treatment of chronic total occlusion with everolimus or sirolimus eluting stents.
|
Int J Cardiol
|
2012
|
0.77
|
|
106
|
Correlation between optical coherence tomography-derived intraluminal parameters and fractional flow reserve measurements in intermediate grade coronary lesions: a comparison between diabetic and non-diabetic patients.
|
Clin Res Cardiol
|
2014
|
0.77
|
|
107
|
Renin-angiotensin-aldosterone system antagonists and the prevention of type 2 diabetes mellitus.
|
Curr Pharm Des
|
2012
|
0.77
|
|
108
|
C-Peptide in the vessel wall.
|
Rev Diabet Stud
|
2009
|
0.77
|
|
109
|
Correlation between OCT-derived intrastent dimensions and fractional flow reserve measurements after coronary stent implantation and impact on clinical outcome.
|
J Invasive Cardiol
|
2015
|
0.77
|
|
110
|
Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
|
Am J Cardiol
|
2011
|
0.77
|
|
111
|
Computational Electrocardiography: Revisiting Holter ECG Monitoring.
|
Methods Inf Med
|
2016
|
0.77
|
|
112
|
Rate and irregularity of electrical activation during atrial fibrillation affect myocardial NGF expression via different signalling routes.
|
Cell Signal
|
2011
|
0.77
|
|
113
|
Layer-specific analysis of myocardial function for accurate prediction of reversible ischaemic dysfunction in intermediate viability defined by contrast-enhanced MRI.
|
Heart
|
2011
|
0.77
|
|
114
|
Pulmonary perfusion imaging: new insights into functional consequences of pulmonary embolism using a multicomponent cardiovascular magnetic resonance imaging protocol.
|
J Am Coll Cardiol
|
2012
|
0.76
|
|
115
|
Combined computational and experimental approach to improve the assessment of mitral regurgitation by echocardiography.
|
Ann Biomed Eng
|
2014
|
0.76
|
|
116
|
Long-term clinical outcome of sirolimus-eluting stent implantation in metabolic syndrome and diabetes.
|
J Invasive Cardiol
|
2010
|
0.76
|
|
117
|
In vivo study on the expression pattern of resistin in patients with abdominal aortic aneurysm.
|
Vasc Endovascular Surg
|
2010
|
0.76
|
|
118
|
Long-term outcome after angiographically proven coronary stent thrombosis.
|
Am J Cardiol
|
2013
|
0.76
|
|
119
|
Biochemical markers and somatosensory evoked potentials in patients after cardiac arrest: the role of neurological outcome scores.
|
J Neurol Sci
|
2011
|
0.76
|
|
120
|
Serum levels of C-peptide are associated with coronary artery calcification in patients with rheumatoid arthritis.
|
Rheumatol Int
|
2015
|
0.76
|
|
121
|
Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension.
|
Diabetes Res Clin Pract
|
2010
|
0.76
|
|
122
|
Efficacy and safety of transcatheter coil embolization in congenital coronary artery fistulas guided by preinterventional cardiac computed tomography.
|
Coron Artery Dis
|
2013
|
0.76
|
|
123
|
Beat to beat 3-dimensional intracardiac echocardiography: theoretical approach and practical experiences.
|
Int J Cardiovasc Imaging
|
2012
|
0.76
|
|
124
|
[Not Available].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
|
125
|
[Is intensive glycemic control for patients with type 2 diabetes profitable? - Diabetes therapy should be more individualised].
|
Dtsch Med Wochenschr
|
2014
|
0.75
|
|
126
|
Percutaneous edge-to-edge mitral valve repair: assessment of immediate post-procedural treatment effect using color 3-dimensional transesophageal echocardiography and cardiac magnetic resonance imaging.
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
127
|
PPARgamma and vascular inflammation: adding another piece to the puzzle.
|
Circ Res
|
2002
|
0.75
|
|
128
|
Cardiovascular effects of diabetes drugs: making the dark ages brighter with Carolina.
|
Ann Intern Med
|
2013
|
0.75
|
|
129
|
Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm.
|
Vasc Health Risk Manag
|
2008
|
0.75
|
|
130
|
New antidiabetic therapies: innovative strategies for an old problem.
|
Curr Opin Lipidol
|
2012
|
0.75
|
|
131
|
Three-dimensional contrast-enhanced and non-contrast-enhanced cardiac magnetic resonance imaging for the assessment of myocardial ischemic reactions: the practice of looking deeply into the myocardium.
|
J Nucl Cardiol
|
2011
|
0.75
|
|
132
|
[Atrial fibrillation: therapy gets more and more individualized].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
|
133
|
[ST-elevation myocardial infarction: angiotensin receptor blockers are effective with preserved ejection fraction].
|
Dtsch Med Wochenschr
|
2015
|
0.75
|
|
134
|
[Parachute Implantation in Severe Ischemic Cardiomyopathy].
|
Dtsch Med Wochenschr
|
2017
|
0.75
|
|
135
|
[The Role of Intensive Care Medicine after Interventional Heart Valve Therapy].
|
Dtsch Med Wochenschr
|
2017
|
0.75
|
|
136
|
Diabetes and acute coronary syndromes--a cardiologist's view.
|
Diab Vasc Dis Res
|
2005
|
0.75
|
|
137
|
Tick-tock: is your cardiometabolic risk on the clock?
|
Diab Vasc Dis Res
|
2014
|
0.75
|
|
138
|
Two-year mortality after transcatheter aortic valve implantation versus medical therapy for high-surgical risk or inoperable aortic stenosis patients.
|
J Heart Valve Dis
|
2013
|
0.75
|
|
139
|
Irregular electrical activation of intrinsic cardiac adrenergic cells increases catecholamine-synthesizing enzymes.
|
Biochem Biophys Res Commun
|
2011
|
0.75
|
|
140
|
[Magnesium: a kardio-renal viewpoint].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
|
141
|
[ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].
|
Kardiol Pol
|
2013
|
0.75
|
|
142
|
Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents.
|
Coron Artery Dis
|
2013
|
0.75
|
|
143
|
[Valvular Diseases and Severe Heart Failure: Cooperation in the Heart Team].
|
Dtsch Med Wochenschr
|
2017
|
0.75
|
|
144
|
Effect of preinterventional ultrasound examination on frequency of procedure-related vascular complications in percutaneous coronary interventions with transfemoral approach.
|
Am J Cardiol
|
2011
|
0.75
|
|
145
|
Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration.
|
Acta Cardiol
|
2011
|
0.75
|
|
146
|
[Sacubitril / Valsartan in patients with diabetes and heart failure].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
|
147
|
[Non-ST-Segment Elevation Myocardial Infarction Caused by Spontaneous Coronary Thrombosis by Intimal Rupture].
|
Dtsch Med Wochenschr
|
2017
|
0.75
|
|
148
|
Focussed section "Effect of oral antidiabetic drugs on micro- and macrovascular complications in patients with diabetes mellitus--update 2008".
|
Cardiovasc Drugs Ther
|
2008
|
0.75
|
|
149
|
Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
|
Coron Artery Dis
|
2012
|
0.75
|